Does the prescription of anxiolytic and hypnotic drugs increase mortality in older adults?

Journal of the American Geriatrics Society

Volumn 63, Issue 6, 2015, Pages 1263-1265

  Pinot, Juliette ^a   Herr, Marie ^a   Robine, Jean Marie ^b   Aegerter, Philippe ^a   Arvieu, Jean Jacques ^c   Ankri, Joel ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c Accidents et Risques Divers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BROMAZEPAM; HYPNOTIC AGENT; LORAZEPAM; ZOLPIDEM; ZOPICLONE; HYPNOTIC SEDATIVE AGENT;

AGED; FOLLOW UP; GERIATRIC DISORDER; HUMAN; LETTER; MAJOR CLINICAL STUDY; MORTALITY; PRESCRIPTION; PROPENSITY SCORE; VERY ELDERLY; AGE; COHORT ANALYSIS; FEMALE; FRANCE; MALE; PROPORTIONAL HAZARDS MODEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; COHORT STUDIES; FEMALE; FRANCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MORTALITY; PROPORTIONAL HAZARDS MODELS;

EID: 84931382137     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13466     Document Type: Letter

References (9)

1. Charlson F, Degenhardt L, McLaren J, et al., A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf 2009; 18: 93-103.
2. Weich S, Pearce HL, Croft P, et al., Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: Retrospective cohort study. BMJ 2014; 348: g1996.
3. Belleville G,. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. Can J Psychiatry 2010; 55: 558-567.
4. Kripke DF, Langer RD, Kline LE,. Hypnotics' association with mortality or cancer: A matched cohort study. BMJ open 2012; 2: e000850.
5. Kripke DF, Klauber MR, Wingard DL, et al., Mortality hazard associated with prescription hypnotics. Biol Psychiatry 1998; 43: 687-693.
6. Vinkers DJ, Gussekloo J, van der Mast RC, et al., Benzodiazepine use and risk of mortality in individuals aged 85 years or older. JAMA 2003; 290: 2942-2943.
7. Hogan DB, Maxwell CJ, Fung TS, et al., Prevalence and potential consequences of benzodiazepine use in senior citizens: Results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 2003; 10: 72-77.
8. Gisev N, Hartikainen S, Chen TF, et al., Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: A population-based retrospective cohort study. Can J Psychiatry 2011; 56: 377-381.
9. Jaussent I, Ancelin ML, Berr C, et al., Hypnotics and mortality in an elderly general population: A 12-year prospective study. BMC Med 2013; 11: 212.